Home Cart 0 Sign in  
X

[ CAS No. 2739-97-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2739-97-1
Chemical Structure| 2739-97-1
Chemical Structure| 2739-97-1
Structure of 2739-97-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2739-97-1 ]

Related Doc. of [ 2739-97-1 ]

Alternatived Products of [ 2739-97-1 ]

Product Details of [ 2739-97-1 ]

CAS No. :2739-97-1 MDL No. :MFCD00006346
Formula : C7H6N2 Boiling Point : -
Linear Structure Formula :- InChI Key :UKVQBONVSSLJBB-UHFFFAOYSA-N
M.W : 118.14 Pubchem ID :75959
Synonyms :

Calculated chemistry of [ 2739-97-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 33.76
TPSA : 36.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.22
Log Po/w (XLOGP3) : 0.6
Log Po/w (WLOGP) : 1.15
Log Po/w (MLOGP) : 0.13
Log Po/w (SILICOS-IT) : 1.65
Consensus Log Po/w : 0.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.38
Solubility : 4.95 mg/ml ; 0.0419 mol/l
Class : Very soluble
Log S (Ali) : -0.94
Solubility : 13.4 mg/ml ; 0.114 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.46
Solubility : 0.406 mg/ml ; 0.00344 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.16

Safety of [ 2739-97-1 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P262-P264-P270-P271-P280-P280-P301+P310+P330-P302+P350+P310-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P361-P403+P233-P405-P501 UN#:3439
Hazard Statements:H301-H310-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2739-97-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2739-97-1 ]
  • Downstream synthetic route of [ 2739-97-1 ]

[ 2739-97-1 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 2739-97-1 ]
  • [ 2706-56-1 ]
Reference: [1] Applied Organometallic Chemistry, 2018, vol. 32, # 9,
  • 2
  • [ 372-48-5 ]
  • [ 75-05-8 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 24, p. 10186 - 10189
  • 3
  • [ 5451-39-8 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of the American Chemical Society, 2018, vol. 140, # 5, p. 1627 - 1631
[2] Journal of the American Chemical Society, 1951, vol. 73, p. 5752,5756
  • 4
  • [ 109-04-6 ]
  • [ 75-05-8 ]
  • [ 2739-97-1 ]
Reference: [1] Synlett, 2000, # 10, p. 1488 - 1490
  • 5
  • [ 109-04-6 ]
  • [ 928664-98-6 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 18, p. 6948 - 6951
  • 6
  • [ 117504-08-2 ]
  • [ 2739-97-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1990, vol. 38, # 6, p. 1513 - 1517
  • 7
  • [ 109-09-1 ]
  • [ 75-05-8 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 24, p. 10186 - 10189
  • 8
  • [ 2706-56-1 ]
  • [ 2739-97-1 ]
Reference: [1] Synlett, 2004, # 12, p. 2180 - 2184
  • 9
  • [ 773837-37-9 ]
  • [ 6959-47-3 ]
  • [ 2739-97-1 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 11, p. 1875 - 1883
  • 10
  • [ 109-04-6 ]
  • [ 75-05-8 ]
  • [ 504-29-0 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of Organic Chemistry, 1983, vol. 48, # 14, p. 2392 - 2399
  • 11
  • [ 55401-97-3 ]
  • [ 2739-97-1 ]
Reference: [1] Journal of the Chemical Society [Section] A: Inorganic, Physical, Theoretical, [2] Journal of the Chemical Society [Section] A: Inorganic, Physical, Theoretical, 1968, p. 923 - 929
[3] , Gmelin Handbook: Co: Org.Verb.1, 1.1.3.1.1.2, page 58 - 65,
  • 12
  • [ 54765-14-9 ]
  • [ 2739-97-1 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 408 - 416
  • 13
  • [ 1221640-05-6 ]
  • [ 2739-97-1 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 408 - 416
  • 14
  • [ 586-98-1 ]
  • [ 2739-97-1 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 11, p. 1875 - 1883
  • 15
  • [ 151-50-8 ]
  • [ 6959-47-3 ]
  • [ 2739-97-1 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1956, vol. 289, p. 448,450
[2] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[3] Chem.Abstr., 1956, p. 1808
[4] Roczniki Chemii, 1957, vol. 31, p. 543,547,550[5] Chem.Abstr., 1958, p. 5406
  • 16
  • [ 110-86-1 ]
  • [ 75-05-8 ]
  • [ 2739-97-1 ]
  • [ 6443-85-2 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 36, p. 3793 - 3795
  • 17
  • [ 694-59-7 ]
  • [ 110-86-1 ]
  • [ 142-08-5 ]
  • [ 2739-97-1 ]
  • [ 366-18-7 ]
  • [ 109-97-7 ]
Reference: [1] Heterocycles, 1990, vol. 31, # 5, p. 783 - 786
  • 18
  • [ 110-86-1 ]
  • [ 75-05-8 ]
  • [ 2739-97-1 ]
  • [ 6443-85-2 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 36, p. 3793 - 3795
  • 19
  • [ 67-56-1 ]
  • [ 2739-97-1 ]
  • [ 1658-42-0 ]
Reference: [1] ChemMedChem, 2015, vol. 10, # 11, p. 1875 - 1883
  • 20
  • [ 2739-97-1 ]
  • [ 75-36-5 ]
  • [ 57115-24-9 ]
YieldReaction ConditionsOperation in experiment
29% With sodium ethanolate In tetrahydrofuran at 10℃; for 16 h; [507] To a solution of 2-(2-pyridyl)acetonitrile (2,00 g, 16,93 mmol, 1.83 mL, 1 ,00 eg) in THF (5 mL) was added EtONa (3.46 g, 50.79 mmol, 3.00 eg) and formyl chloride (2.18 g, 33.86 mmol, 2.00 eg). The reaction mixture was stirred at 10 °C for 16 h. TLC (ethyl acetate) indicated -40percent of SM remained and one major new spot formed. The reaction mixture was diluted with water (50 mL), and adjusted to pH=5 with sat. aq. KHSO4 solution. Then the resulting mixture was extracted with ethyl acetate (50 mL χ 3). The organic layers were combined, dried over anhydrous NazSC , filtered and concentrated under reduced pressure to give a residue, which was purified by column chromatography on silica gel (5- 50percent ethyl acetate/petroleum ether) to afford 3-oxo-2-(2-pyridyl)butanenitrile (780 mg, 4.87 mmol, 29percent yield) as a yellow solid. LC-MS (ESI): m/z 161.0 { .M 1 I s ' .
Reference: [1] Patent: WO2017/210678, 2017, A1, . Location in patent: Paragraph 506; 507
  • 21
  • [ 2739-97-1 ]
  • [ 35853-55-5 ]
Reference: [1] Tetrahedron, 1991, vol. 47, # 36, p. 7609 - 7614
[2] Tetrahedron, 1991, vol. 47, # 36, p. 7609 - 7614
  • 22
  • [ 2739-97-1 ]
  • [ 118753-70-1 ]
  • [ 167263-04-9 ]
YieldReaction ConditionsOperation in experiment
44% With sodium hydride In DMF (N,N-dimethyl-formamide); oil at 0 - 60℃; for 5.63333 h; Sodium hydride (60percent in mineral oil, 2.04g, 51mmol) was added portion wise over 8 minutes to a stirring solution of 2-pyridineacetonitrile (1. 8ml, 17mmol) and N- (tert-butyloxycarbonyl) bis (2-chloroethyl) amine in anhydrous DMF (50ml) at 0OC. The reaction was then heated at 60°C for 5 1/2hours. The reaction was cooled and extracted into ethyl acetate (4 x 150ml), and washed with water (3 x 200ml). The organic layer was then dried over anhydrous MgSO.cents., filtered and evaporated in vacuo to give a red/black oil. This was absorbed onto silica and purified by column chromatography using 20percent ethyl acetate in isohexane to give ter-butyl 4-cyano-4-pyridin-2-ylpiperidine-1-carboxylate as an orange solid (2.13g, 44percent). 1H NMR 8 (ppm) 360MHz (CDC13): 1.48 (9 H, s), 2.04-2. 08 (2 H, m), 2.17-2. 25 (2 H, m), 3.15-3. 28 (2 H, m), 4.20-4. 35 (2 H, m), 7.25-7. 29 (1 H, m), 7.61 (1 H, d, J = 8Hz), 7.73-7. 78 (1 H, m), 8. 61 (1 H, dd, J = 0.7, 3.9Hz). MSp m/z for MH+ = 287 (- 56).
Reference: [1] Patent: WO2005/51390, 2005, A1, . Location in patent: Page/Page column 28
[2] Bioorganic and medicinal chemistry letters, 2000, vol. 10, # 15, p. 1625 - 1628
[3] Patent: US5635510, 1997, A,
[4] Patent: US5824690, 1998, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2739-97-1 ]

Nitriles

Chemical Structure| 1531-18-6

[ 1531-18-6 ]

2-Ethylisonicotinonitrile

Similarity: 0.85

Chemical Structure| 1620-75-3

[ 1620-75-3 ]

6-Methylpicolinonitrile

Similarity: 0.80

Chemical Structure| 39965-81-6

[ 39965-81-6 ]

2,6-Dimethylisonicotinonitrile

Similarity: 0.73

Chemical Structure| 159307-02-5

[ 159307-02-5 ]

6-Acetylpicolinonitrile

Similarity: 0.72

Chemical Structure| 2893-33-6

[ 2893-33-6 ]

Pyridine-2,6-dicarbonitrile

Similarity: 0.72

Related Parent Nucleus of
[ 2739-97-1 ]

Pyridines

Chemical Structure| 1531-18-6

[ 1531-18-6 ]

2-Ethylisonicotinonitrile

Similarity: 0.85

Chemical Structure| 2706-56-1

[ 2706-56-1 ]

2-Pyridylethylamine

Similarity: 0.83

Chemical Structure| 644-98-4

[ 644-98-4 ]

2-Isopropylpyridine

Similarity: 0.81

Chemical Structure| 126553-00-2

[ 126553-00-2 ]

6-Ethylpyridin-3-amine

Similarity: 0.81

Chemical Structure| 1620-75-3

[ 1620-75-3 ]

6-Methylpicolinonitrile

Similarity: 0.80